secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)
CIK:        0001335105
Form:       8-K
Filed at:   2024-05-29T23:59:59+00:00
Accession:  0001493152-24-021837
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Lixte Biotechnology notifies CMO James Miser of non-renewal; employment ends July 31, 2024
--------------------------------------------------------------------------------

- Dr. James Miser's employment agreement not renewed; CMO role ends July 31, 2024.
- Lixte intends to appoint a new Chief Medical Officer effective August 1, 2024.
- Notice of non-renewal provided to Dr. Miser on May 24, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1335105/000149315224021837/0001493152-24-021837-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1335105/000149315224021837/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-021837

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer